Pain Medication Prescriptions and Misuse Following Treatment for Alcohol Use Disorders
酒精使用障碍治疗后的止痛药处方和滥用
基本信息
- 批准号:10442656
- 负责人:
- 金额:$ 32.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccidentsAcuteAcute PainAddressAdherenceAdmission activityAdultAdverse eventAgeAlcohol abuseAlcohol consumptionAlcohol dependenceAlcoholismAlcoholsAnalgesicsBenzodiazepinesCessation of lifeChronicClientClinicalDataData SetDatabasesDiagnosisDiseaseDoseDropoutDrug usageExhibitsFailureFamily history ofFeelingGoalsHealthIndividualInformation SystemsInjuryLeadLinkMedicaidMedicalMental disordersMorbidity - disease rateMotivationNatureNew YorkOpioidOverdosePainPatientsPharmaceutical PreparationsPharmacotherapyPhysiciansPopulationPrevalencePrimary Health CarePropertyRecording of previous eventsRecordsRegimenRelapseReportingRiskSamplingSeriesServicesSubstance Use DisorderSubstance abuse problemSystemTestingTimeTreatment FactorUpdateViolenceadverse outcomealcohol abuse therapyalcohol availabilityalcohol involvementalcohol use disorderchronic alcohol ingestionchronic painchronic pain managementdrug misuseemotional abuseexperiencehigh riskmisuse of prescription only drugsmortalityneural circuitopioid misusephysical abusepolicy implicationprescription opioidprescription pain relieverproblem drinkerrelapse predictionsubstance usetreatment programtreatment services
项目摘要
Abstract
There are critical links between alcohol use disorder (AUD) and pain that have been largely ignored until
recently. For example, individuals with alcohol dependence often experience physical injuries from accidents
and violence that have a lasting physical impact. Chronic alcohol use can also lead to physical conditions that
produce significant pain. Similarly, AUDs can also lead to poor adherence to medical regimens for diseases
which can result in exacerbation in pain. Finally, given that common neural circuits are impacted by chronic
pain and by alcohol dependence, alcohol dependence may lead to heightened feelings of pain, and that such
pain may lead to alcohol use for its analgesic properties. Given these linkages between AUDs and chronic
pain, it is not surprising to find significant proportions of individuals with AUD report that they experience
significant pain and are in treatment for chronic pain. The presence of chronic pain among individuals with
AUD, combined with the chronic, relapsing nature of alcohol use disorders raises the possibility that individuals
with an alcohol use disorder may seek treatment for chronic pain, receive opioid and/or benzodiazepine
prescriptions for pain, and be at risk for morbidity and mortality associated with using these medications,
particularly in conjunction with excessive alcohol use. This study proposes to integrate records from the Client
Data System of the New York State Office of Alcoholism and Substance Abuse Services (OASAS) patient
records with New York State Medicaid records. We plan to identify approximately 214,000 Medicaid patients
with a first contact with the OASAS treatment system from 2006-2014 and merge these treatment records with
their Medicaid claims records from their initial treatment contact through 2015. In addition, we will draw a
sample three times as large of matched individuals from the Medicaid claims to serve as a comparison sample.
Hypotheses will address the extent to which individuals with a history of treatment for alcohol problems are at
increased risk for receiving prescriptions for opioids and benzodiazepine for pain and whether this is because
of an increased risk of pain diagnoses, or whether this risk remains after controlling for diagnoses. We will also
determine if alcohol treatment patients are at further risk for higher doses, longer durations, and
misuse/overdose from these substances, and whether pain diagnoses account for this risk. Moreover, the
integration of these datasets will allow us to identify factors in the existing treatment records that would identify
individuals most at risk for the excessive use and misuse of these medications. These findings will have
important clinical implications for the management of patients in primary care with an unrecognized history of
an alcohol use disorder and policy implications with respect to medical access to alcohol treatment records.
抽象的
酒精使用障碍 (AUD) 和疼痛之间存在重要联系,但直到现在,这些联系在很大程度上被忽视了。
最近。例如,酒精依赖者经常会因事故而遭受身体伤害
以及对身体造成持久影响的暴力。长期饮酒也会导致身体状况
产生明显的疼痛。同样,AUD 也会导致疾病治疗的依从性较差
这可能会导致疼痛加剧。最后,考虑到常见的神经回路受到慢性影响
疼痛和酒精依赖,酒精依赖可能会导致疼痛感加剧,并且这种情况
疼痛可能会导致饮酒,因为它具有镇痛作用。鉴于澳元与慢性病之间的这些联系
痛苦,毫不奇怪地发现很大一部分患有 AUD 的人报告说他们经历过
严重疼痛并正在治疗慢性疼痛。患有慢性疼痛的个体存在
AUD,加上酒精使用障碍的慢性、复发性,增加了个体以下可能性:
患有酒精使用障碍的人可能会寻求慢性疼痛的治疗,接受阿片类药物和/或苯二氮卓类药物
疼痛处方,并面临与使用这些药物相关的发病率和死亡风险,
特别是与过量饮酒有关。本研究建议整合客户的记录
纽约州酗酒和药物滥用服务办公室 (OASAS) 患者数据系统
记录与纽约州医疗补助记录。我们计划识别大约 214,000 名医疗补助患者
2006-2014 年首次接触 OASAS 治疗系统,并将这些治疗记录与
他们从最初接触治疗到 2015 年的医疗补助索赔记录。此外,我们将绘制一份
从医疗补助声称中抽取三倍大的匹配个体作为比较样本。
假设将解决有酗酒问题治疗史的个体在多大程度上处于酒精问题的状态。
接受阿片类药物和苯二氮卓类止痛处方的风险增加,这是否是因为
疼痛诊断的风险增加,或者在控制诊断后这种风险是否仍然存在。我们也会
确定酒精治疗患者是否因更高剂量、更长持续时间而面临进一步风险,以及
这些物质的误用/过量,以及疼痛诊断是否会导致这种风险。此外,
这些数据集的整合将使我们能够识别现有治疗记录中的因素,从而确定
最有可能过度使用和滥用这些药物的人。这些发现将有
对于初级保健中具有未识别病史的患者的管理具有重要的临床意义
酒精使用障碍以及对酒精治疗记录的医疗获取的政策影响。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ICD9-CM Claims Data are Insufficient for Influenza Surveillance.
ICD9-CM 声称数据不足以进行流感监测。
- DOI:
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:Elkin, Peter L;Brown, Steven H
- 通讯作者:Brown, Steven H
Can Solo Practitioners Survive in Value-Based Healthcare? Validating a Predicative Model for ED Utilization.
单独从业者可以在基于价值的医疗保健中生存吗?
- DOI:
- 发表时间:2019-08-21
- 期刊:
- 影响因子:0
- 作者:Howell, Pamella;Elkin, Peter L
- 通讯作者:Elkin, Peter L
Comparison of Changes in the Number of Included Patients Between Interventional Trials and Observational Studies Published from 1995 to 2014 in Three Leading Journals.
1995 年至 2014 年在三个领先期刊上发表的干预性试验和观察性研究之间纳入患者数量变化的比较。
- DOI:
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Dezetree, Arnaud;Chazard, Emmanuel;Schlegel, Daniel R;Sakilay, Sylvester;Elkin, Peter L;Ficheur, Grégoire
- 通讯作者:Ficheur, Grégoire
Rosacea Patients Are at Higher Risk for Obstructive Sleep Apnea: Automated Retrospective Research.
红斑痤疮患者患阻塞性睡眠呼吸暂停的风险较高:自动回顾性研究。
- DOI:
- 发表时间:2020-06-16
- 期刊:
- 影响因子:0
- 作者:Elkin, Peter L;Mullin, Sarah;Sakilay, Sylvester
- 通讯作者:Sakilay, Sylvester
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER L. ELKIN其他文献
PETER L. ELKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER L. ELKIN', 18)}}的其他基金
Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education
布法罗基因组和医疗保健技术研究创新 (BRIGHT) 短期培训和教育
- 批准号:
10631367 - 财政年份:2022
- 资助金额:
$ 32.51万 - 项目类别:
National Library of Medicine Conference 2022
2022 年国家医学图书馆会议
- 批准号:
10526993 - 财政年份:2022
- 资助金额:
$ 32.51万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education
布法罗基因组和医疗保健技术研究创新 (BRIGHT) 短期培训和教育
- 批准号:
10631367 - 财政年份:2022
- 资助金额:
$ 32.51万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology (BRIGHT) Short-Term Training and Education
布法罗基因组和医疗保健技术研究创新 (BRIGHT) 短期培训和教育
- 批准号:
10707232 - 财政年份:2022
- 资助金额:
$ 32.51万 - 项目类别:
Pain Medication Prescriptions and Misuse Following Treatment for Alcohol Use Disorders
酒精使用障碍治疗后的止痛药处方和滥用
- 批准号:
10201106 - 财政年份:2020
- 资助金额:
$ 32.51万 - 项目类别:
Pain Medication Prescriptions and Misuse Following Treatment for Alcohol Use Disorders
酒精使用障碍治疗后的止痛药处方和滥用
- 批准号:
10224040 - 财政年份:2020
- 资助金额:
$ 32.51万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology Education (BRIGHT Education)
布法罗基因组和医疗技术教育研究创新(BRIGHT Education)
- 批准号:
10405911 - 财政年份:2017
- 资助金额:
$ 32.51万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology Education (BRIGHT Education)
布法罗基因组和医疗技术教育研究创新(BRIGHT Education)
- 批准号:
9552954 - 财政年份:2017
- 资助金额:
$ 32.51万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology Education (BRIGHT Education)
布法罗基因组和医疗技术教育研究创新(BRIGHT Education)
- 批准号:
10205171 - 财政年份:2017
- 资助金额:
$ 32.51万 - 项目类别:
Buffalo Research Innovation in Genomic and Healthcare Technology Education (BRIGHT Education)
布法罗基因组和医疗技术教育研究创新(BRIGHT Education)
- 批准号:
10617368 - 财政年份:2017
- 资助金额:
$ 32.51万 - 项目类别:
相似国自然基金
电针调控Nrf2表达抑制巨噬细胞铁死亡进程缓解急性痛风性关节炎疼痛的机制研究
- 批准号:82305369
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
急性牙髓炎疼痛昼夜变化的中枢调控新机制:节律基因Per1/HIF-1α轴调控铁代谢介导小胶质细胞差异性极化
- 批准号:82370986
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
前扣带回沉默突触激活介导急性疼痛慢性化的环路和细胞机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
围术期睡眠剥夺激活外周感觉神经元芳香烃受体致术后急性疼痛慢性化
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
从急性到慢性下腰腿痛:默认网络对疼痛的编码作用及其机制的MRI研究
- 批准号:82160331
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
相似海外基金
The Relationship Between Postoperative Prescriber Networks and Opioid Prescribing Discoordination
术后处方者网络与阿片类药物处方不协调之间的关系
- 批准号:
10700876 - 财政年份:2022
- 资助金额:
$ 32.51万 - 项目类别:
Pharmacokinetics and Pharmacodynamics of Oral and Vaporized THC in Older Adults
老年人口服和汽化 THC 的药代动力学和药效学
- 批准号:
10705257 - 财政年份:2022
- 资助金额:
$ 32.51万 - 项目类别:
Pharmacokinetics and Pharmacodynamics of Oral and Vaporized THC in Older Adults
老年人口服和汽化 THC 的药代动力学和药效学
- 批准号:
10569710 - 财政年份:2022
- 资助金额:
$ 32.51万 - 项目类别:
HD2A RASC - Pain Implementation Support Core
HD2A RASC - 疼痛实施支持核心
- 批准号:
10708984 - 财政年份:2022
- 资助金额:
$ 32.51万 - 项目类别:
A Naloxone Parachute: Novel Wearable Dual-Sensor Regional Oximeter to Detect Opioid-Induced Hypoxia and Enable Emergent Naloxone Rescue
纳洛酮降落伞:新型可穿戴双传感器区域血氧计,用于检测阿片类药物引起的缺氧并实现紧急纳洛酮救援
- 批准号:
10612485 - 财政年份:2022
- 资助金额:
$ 32.51万 - 项目类别: